A Dual-Drug Nanosuspension of Bufalin and Quercetin Exhibits Potent Anti-Hepatocellular Carcinoma Activity In vitro and In vivo | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

A Dual-Drug Nanosuspension of Bufalin and Quercetin Exhibits Potent Anti-Hepatocellular Carcinoma Activity In vitro and In vivo

Authors:: Ruirui Song; Bingqian Li; Chengcheng Gao; Zerun Yang; Tiantian Zhu; Yan Sun; Huagang Sheng; Liqiao Zhu

Reference:: Current Drug Delivery; 2025; 22; in press

DOI:: 10.2174/0115672018405334250831225746

See Abstract

Key Words:: Bufalin; quercetin; nanosuspension; hepatocellular carcinoma; HepG2; H22; mice; animal experiments

Back to index